Insulet (PODD) Capital Expenditures (2010 - 2026)

Insulet (PODD) has reported Capital Expenditures for 17 consecutive years, with $32.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Capital Expenditures rose 74.73% year-over-year to $32.5 million; the trailing twelve-month figure through Jun 2026 stood at $217.5 million (up 95.59% YoY), and the FY2025 full-year result was $191.6 million, up 53.4% from the prior year.
• Capital Expenditures grew to $32.5 million in Q2 2026 per PODD's latest filing, from $24.3 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $135.1 million in Q4 2025 and bottomed at $10.5 million in Q1 2023.
• Historically, Capital Expenditures has averaged $31.8 million across 5 years, with a median of $23.4 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Capital Expenditures plunged 61.09% in 2022, then jumped 152.05% in 2025.
• Over 5 years, Capital Expenditures stood at $64.4 million in 2022, then tumbled by 54.5% to $29.3 million in 2023, then surged by 82.94% to $53.6 million in 2024, then surged by 152.05% to $135.1 million in 2025, then plunged by 75.94% to $32.5 million in 2026.
• According to Business Quant data, Capital Expenditures over the past three periods registered $32.5 million, $24.3 million, and $135.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.